AstraZeneca's stock has seen its fair value estimate rise from $134.64 to $138.16 as analysts update their outlook for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback